Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihypertensive drug comparison in patients with impaired fasting glucose and hypertension
ChiCTR-TRC-11001653Phase 4Completed
- Sponsor
- Southwest Health System
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Levamlodipine and losartan in hypertension (HTN) and impaired fasting glucose (IFG) (2 arms), sponsored by Southwest Health System. Primary endpoints: Fasting plasma glucose, 2-hour oral glucose tolerance test plasma glucose and 3 more. Started Jan 2011; status: completed.
02
Drugs
Levamlodipinelosartan
03
Conditions
hypertension (HTN)impaired fasting glucose (IFG)
Beyond the preview
Go deeper on ChiCTR-TRC-11001653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001653.